Projects per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
3.1 Basic medicine, Expert, Latvian Council of Science
5 Oct 2023 → 4 Oct 2026
3.1 Basic medicine, Expert, Latvian Council of Science
18 Jun 2020 → 17 Jun 2023
3.1 Basic medicine, Expert, Latvian Council of Science
17 Aug 2017 → 16 Aug 2020
Field of Science
- 3.1 Basic medicine
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Projects
- 1 Finished
-
Development of new anti-cancer medicines for treatment of rare tumours in triterpenoid group of lupane series
Vilšķērsts, R. (Project leader) & Turks, M. (Project leader)
15/02/16 → 28/02/19
Project: RSU grants
-
Data on cardiac and vascular functionality in ex vivo and in vivo models following acute administration of trimethylamine N-oxide
Videja, M. (Corresponding Author), Vilskersts, R., Sevostjanovs, E., Liepinsh, E. & Dambrova, M., Feb 2023, In: Data in Brief. 46, 108890.Research output: Contribution to journal › Article › peer-review
Open AccessFile11 Downloads (Pure) -
Meldonium increases functional capacity of patients with chronic right ventricular failure
Kigitovica, D., Dzirnieks, K., Sablinskis, M., Lejnieks, A., Vilskersts, R. & Skride, A., 2023, In: Medicina (Kaunas). 59, Suppl.2, p. 212Research output: Contribution to journal › Meeting Abstract › peer-review
Open Access -
Meldonium Therapy Improves the Right Ventricle Function
Kigitovica, D., Korzh, S., Videja, M., Vilks, K., Makrecka-Kuka, M., Liepiņš, E., Skride, A., Dambrova, M. & Vilskersts, R., 2023.Research output: Contribution to conference › Poster
-
Acylcarnitines: Nomenclature, Biomarkers, Therapeutic Potential, Drug Targets, and Clinical Trials
Dambrova, M. (Corresponding Author), Makrecka-Kuka, M., Kuka, J., Vilskersts, R., Nordberg, D., Attwood, M. M., Smesny, S., Sen, Z. D., Guo, A. C., Oler, E., Tian, S., Zheng, J., Wishart, D. S., Liepinsh, E. & Schiöth, H. B. (Corresponding Author), 1 Jul 2022, In: Pharmacological Reviews. 74, 3, p. 506-551 46 p.Research output: Contribution to journal › Review article › peer-review
Open AccessFile179 Citations (Scopus)181 Downloads (Pure) -
Cardioprotection by selective SGLT-2 inhibitors in a non-diabetic mouse model of myocardial ischemia/reperfusion injury: a class or a drug effect?
Nikolaou, P. E., Mylonas, N., Makridakis, M., Makrecka-Kuka, M., Iliou, A., Zerikiotis, S., Efentakis, P., Kampoukos, S., Kostomitsopoulos, N., Vilskersts, R., Ikonomidis, I., Lambadiari, V., Zuurbier, C. J., Latosinska, A., Vlahou, A., Dimitriadis, G., Iliodromitis, E. K. & Andreadou, I. (Corresponding Author), Dec 2022, In: Basic Research in Cardiology. 117, 1, 27.Research output: Contribution to journal › Article › peer-review
36 Citations (Scopus)
Activities
- 2 Oral presentation
-
Meldonium Increases Functional Capacity of Patients with Chronic Right Ventricular Failure
Kigitoviča, D. (Speaker), Dzirnieks, K. (Co-author), Šablinskis, M. (Co-author), Lejnieks, A. (Co-author), Vilšķērsts, R. (Co-author) & Skride, A. (Co-author)
29 Mar 2023Activity: Talk or presentation types › Oral presentation
-
Targeting mitochondrial bioenergetics as a therapeutic strategy for cardiopulmonary complications related to COVID-19
Vilšķērsts, R. (Speaker)
24 Mar 2021Activity: Talk or presentation types › Oral presentation
Press/Media
-
Studies from Latvian Institute of Organic Synthesis Have Provided New Data on Science and Technology (Data on cardiac and vascular functionality in ex vivo and in vivo models following acute administration of trimethylamine N-oxide)
Vilšķērsts, R., Dambrova, M. & Liepiņš, E.
3/02/23
1 item of Media coverage
Press/Media